← All stories
Markets

Hikma (LSE:HIK): Is Contract Manufacturing the Next Growth Engine?

1 source ·1 article ·2h ago

Highlights Contract manufacturing is becoming a larger strategic focus. Injectables are showing signs of greater operational stability. Branded medicines remain supported by regional demand. Hikma Pharmaceuticals is sharpening its growth st…

Covered by 1 outlet

All coverage · 1 article